Objective Clinical Regression of Metastatic Breast Cancer in Disparate Sites after Use of Whole-Cell Vaccine Genetically Modified to Release Sargramostim-Reference-Cited by-同舟云学术

Objective Clinical Regression of Metastatic Breast Cancer in Disparate Sites after Use of Whole-Cell Vaccine Genetically Modified to Release Sargramostim

Published:2006-09 Issue:5 Volume:12 Page:475-480
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast Journal

Author:

Wiseman Charles L.,Kharazi Alex

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1075-122X.2006.00319.x/fullpdf

Reference23 articles.

1. GM-CSF-based cancer vaccines

2. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells

3. Danger: the view from the bottom of the cliff

4. Cancer immunotherapy: moving beyond current vaccines

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer;Human Vaccines & Immunotherapeutics;2024-08-20

2. Regression of Breast Cancer Metastases Following Treatment with Irradiated SV-BR-1-GM, a GM-CSF Overexpressing Breast Cancer Cell Line: Intellectual Property and Immune Markers of Response;Recent Patents on Anti-Cancer Drug Discovery;2023-05

3. Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways;Pharmaceuticals;2021-11-02

4. Dormant Tumor Cell Vaccination: A Mathematical Model of Immunological Dormancy in Triple-Negative Breast Cancer;Cancers;2021-01-11

5. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes;Frontiers in Immunology;2018-05-15